Pragyesh Dhungel is a biotechnology entrepreneur and molecular virologist with over 14 years of experience in research and drug development, ranging from early discovery to clinical-scale drug product manufacturing. As the Co-Founder and executive leader of Mivax Therapeutics, he applies a first-principles approach to overcoming the delivery and scalability hurdles of solid tumor immunotherapies. His technical expertise, honed through research at Sandia National Laboratories and The Scripps Research Institute, is matched by a deep-seated commitment to education and mentorship. With five years of teaching university-level Microbiology at Kansas State University and a track record of mentoring junior scientists and interns, Pragyesh specializes in breaking down complex concepts and guiding teams through experimental unknowns. By merging the rigor of a seasoned researcher with the communication skills of a dedicated educator, he translates advanced scientific discoveries into high-performing teams and real-world therapeutic solutions.
Back to All Events